The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized, open-label 3-arm clinical trial of fulvestrant (F) plus goserelin (G) versus anastrozole (A) plus goserelin (G) versus goserelin (G) alone for hormone receptor (HR) positive, tamoxifen (T) pretreated premenopausal women with recurrent or metastatic breast cance r(MBC) (KCSG BR10-04).
 
Ji-Yeon Kim
No Relationships to Disclose
 
Seock-Ah Im
No Relationships to Disclose
 
Kyung Hae Jung
No Relationships to Disclose
 
Jungsil Ro
No Relationships to Disclose
 
Joohyuk Sohn
No Relationships to Disclose
 
Jee Hyun Kim
No Relationships to Disclose
 
Yeon Hee Park
No Relationships to Disclose
 
Tae Yong Kim
No Relationships to Disclose
 
Sung-Bae Kim
No Relationships to Disclose
 
Keun-Seok Lee
No Relationships to Disclose
 
Gun Min Kim
No Relationships to Disclose
 
Se Hyun Kim
No Relationships to Disclose
 
Jin Seok Ahn
No Relationships to Disclose
 
Kyung-Hun Lee
No Relationships to Disclose
 
Jin-Hee Ahn
No Relationships to Disclose
 
In Hae Park
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose